RALLYBIO CORPORATION Weighted Average Number of Shares Outstanding, Basic and Diluted
RALLYBIO CORPORATION (RLYB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 30.32 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-10
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 30.32M shares, a 36.29% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 30.04M shares, a 35.11% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 27.53M shares, a 24.32% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 3.98M shares, a 50.47% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 25.52M shares, a 46.76% increase from fiscal 2020.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 17.39M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 30.32M shares 10-Q · filed 2022-05-10 | 30.18M shares derived: average of 2 quarters · filed 2022-05-10 | 29.30M shares derived: average of 3 quarters · filed 2022-05-10 | 22.97M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 30.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 28.78M shares derived: average of 2 quarters · filed 2022-03-15 | 20.52M shares derived: average of 3 quarters · filed 2022-03-15 | 25.52M shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 27.53M shares 10-Q · filed 2021-11-10 | 15.75M shares derived: average of 2 quarters · filed 2021-11-10 | 24.01M shares 10-Q · filed 2021-11-10 | 19.00M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2021-06-30 | 3.98M shares 10-Q · filed 2021-09-09 | 3.60M shares 10-Q · filed 2021-09-09 | 16.15M shares derived: average of 3 quarters · filed 2022-05-10 | 17.65M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2021-03-31 | 22.24M shares 10-Q · filed 2022-05-10 | 22.24M shares derived: average of 2 quarters · filed 2022-05-10 | 22.21M shares derived: average of 3 quarters · filed 2022-05-10 | 17.32M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 22.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 22.19M shares derived: average of 2 quarters · filed 2022-03-15 | 15.67M shares derived: average of 3 quarters · filed 2022-03-15 | 17.39M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 22.14M shares 10-Q · filed 2021-11-10 | 12.39M shares derived: average of 2 quarters · filed 2021-11-10 | 15.77M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 2.64M shares 10-Q · filed 2021-09-09 | 2.30M shares 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |